未登录

S

Sarah P. Shubeck

university of chicago

H指数:16

被引数:700

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TWO-YEAR IMPACT OF A WOMEN SURGEONS COMMITTEE ON CULTURE AND ADVOCACY AT AN ACADEMIC MEDICAL CENTER

妇女外科委员会对学术医疗中心文化和倡导工作的两年影响

Journal of Urology

IF6.8

2026-05-010

PRE

Breast Conserving Therapy versus Mastectomy in Young Women: Oncologic and Quality of Life Outcomes

年轻女性乳腺癌保乳治疗与乳房切除术的比较：肿瘤学结果和生活质量结局

Current Breast Cancer Reports

IF0.9

2026-05-011

PRE

Understanding What Surgical Advanced Practiced Providers Want: A Survey of Autonomy, Tasks, and Training Preferences Across Three Institutions

理解外科高级实践提供者想要什么：一项关于自主权、任务和培训偏好的三项机构调查

The American Journal of Surgery

IF0

2026-04-160

PRE

Social vulnerability is associated with advanced breast cancer presentation and all-cause mortality: a retrospective cohort study

BREAST CANCER RESEARCH

IF5.6

2024-12-031

OAAI

Immunotherapy for triple-negative breast cancer in the US: National trends, racial/ethnic disparities, and oncologic outcomes

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2024-09-210

PRE

Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-09-091

OAAI

Quantitative Biomarkers and 21-Gene Assay Results Predict Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Validation of the RSClin risk calculator in the National Cancer Data Base

IF5.1

2023-12-263

OAAI

Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients

NPJ BREAST CANCER

IF7.6

2023-05-069

OAAI

Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US

JAMA NETWORK OPEN

IF9.7

2023-03-3016

OAAI

Evaluation of Multigene Assays as Predictors for Response to Neoadjuvant Chemotherapy in Early-Stage Breast Cancer Patients

CANCER RESEARCH

IF16.6

2023-03-010

PRE

ASO Visual Abstract: Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery and Those Treated With Mastectomy

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-06-050

PRE

Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-05-1815

OA

De-escalation in breast cancer surgery COMMENT

NPJ BREAST CANCER

IF7.6

2022-02-2329

OAAI

Incremental Spending Associated with Low-Value Treatments in Older Women with Breast Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2021-09-2310

PRE

Variations in Persistent Use of Low-Value Breast Cancer Surgery

IF14.9

2021-04-0131

OA

Barriers and Facilitators to De-Implementation of the Choosing Wisely® Guidelines for Low-Value Breast Cancer Surgery

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2020-03-0255

OA

Incidence and Efficacy of Stent Placement in Leak Management After Bariatric Surgery An MBSAQIP Analysis

ANNALS OF SURGERY

IF6.4

2020-01-019

PREAI

Reflections on a leadership development program: Impacts on culture in a surgical environment

IF2.7

2019-11-017

PREAI

Got Milk? Design and Implementation of a Lactation Support Program for Surgeons

ANNALS OF SURGERY

IF6.4

2019-07-0121

OAAI